The Reporter article on the annual Rockin’ Hops music festival held in support of raising awareness and funding for neurofibromatosis, a genetic disorder that affects the nervous system, Larry Sherman, Ph.D., tells a group of parents and supporters who gathered for the presentation, “So let people know and talk to your legislators to know that these kind of cuts are not acceptable. If we close our labs, there is no telling how much data will be lost.”

Story highlights research from OHSU and collaborating organizations that demonstrates how a model of artificial intelligence can better predict survival from glioblastoma and what type of treatment yielded the best outcomes. Ramon Barajas Jr., M.D., says, “We suspected that patients undergoing more aggressive surgery would have positive outcomes. However, applying our model to data from a prospective study, which included other forms of treatment and patient variables, gave us a truly objective assessment of this surgical approach and its impact on survival.”

The Lund Report publishes a story on a new nanoparticle developed by OHSU researchers that makes cancer treatment safer and more effective. Michael Henderson, B.A., says the research “lays the foundation for a new kind of nanoparticle-based therapy that could improve how we approach hard-to-treat tumors.”

Oregon Health & Science University researchers say they have created a new “one-two punch” to be used to combat hard-to-manage cancerous tumors.

A commentary piece in the Oregon Capital Chronicle on the 340B drug discount program mentions OHSU and other hospitals.

A story in Psy Post highlights how brain connectivity patterns differ in children and adolescents diagnosed with generalized anxiety disorder. Study author Sam A. Sievertsen, a Ph.D. student in clinical psychology, says, “Generalized anxiety disorder emerges in childhood or adolescence for some individuals, but a lot of what we know about brain connectivity comes from adult studies.”

Ahmad Masri, M.D., is among leading experts interviewed by HCP Live about the latest treatment advancements for amyloidosis.

In a KGW-TV story about a proposed state law allowing foster youths to be placed out of state for housing and treatment, Ajit Jetmalani, M.D., says, “There are many, many reports of potential abuse or neglect that are not founded. Each one of these reports causes the [medical provider] to be anxious, fearful for their jobs and their livelihoods.”

An oft-ignored type of brain cell plays a dynamic and surprisingly complex role in our ability to process information, according to an OHSU study published in the journal Science. Marc Freeman, Ph.D., says, “We hope this begins to fundamentally change how the field thinks about astrocytes and their role in mediating neurophysiology and behavior. Over the long run, it should change how people think about developing therapies for regulation of attention, anxiety and mood.”

P. Barton Duell, M.D., is the featured guest on a Rarecast podcast, speaking about the role OHSU played in developing a diagnostic and advancing a treatment for CTX, or Cerebrotendinous Xanthomatosis, a rare autosomal recessive genetic disorder, and the critical interplay between academic health centers, patient advocates and drug developers to address the needs of people with rare diseases.